Feb 04 Watch 3:59 News Wrap: Embattled pharma CEO takes Fifth before Congress By PBS News Hour In our news wrap Thursday, embattled ex-Turing Pharmaceuticals CEO Martin Shkreli pleaded the Fifth when called to testify before Congress on drug pricing protocols. Also, 12.7 million Americans signed up for private health insurance under the Affordable Care Act this… Continue watching
Dec 25 Watch 6:18 How drug companies are gaming an old law for greater profits By PBS News Hour In the 1980s, a law was passed to persuade pharmaceutical companies to develop drugs for small populations, but now that rule is being used to reclaim old "orphaned" drugs in order to raise prices and profits. Gwen Ifill learns more… Continue watching
Sep 29 Watch 7:08 Is profit or innovation driving the rising costs of drugs? By PBS News Hour Turing Pharmaceuticals sparked outcry when it raised the price of a single pill from $13 to $750. Judy Woodruff discusses the rising costs of prescriptions drugs with Dr. Peter Bach of Memorial Sloan Kettering Cancer Center and Dr. Thomas Stossel… Continue watching
Sep 23 After controversy, pharmaceutical company will lower price of AIDS drug By Michelle Harven After outrage from the public and even presidential candidates, Turing Pharmaceuticals has announced it will reduce the price of the drug whose cost had previously increased by more than 5,000 percent practically overnight. Continue reading
Jun 10 Watch 7:03 Powerful new class of cholesterol drugs offers hope for some patients By PBS News Hour More than 30 million Americans take statins to lower their cholesterol, according to estimates. But these popular drugs don't work for everyone. Now the FDA may be poised to approve a powerful new class of drugs that can attack cholesterol… Continue watching
Apr 20 Drugmaker settles for $512 million in suit over delayed generics By Megan Thompson Pharmaceutical maker Teva has agreed to a settlement of $512 million in a class action lawsuit over the wakefulness drug Provigil. Drug wholesalers and retailers claimed a generic version of the drug was delayed to market by so-called “pay for… Continue reading
Jan 19 The wealthiest are getting wealthier, and lobbying has a lot to do with it By Simone Pathe On the eve of the president's State of the Union address and the World Economic Forum, Oxfam is predicting a widening wealth gap and pointing a finger at the millions of dollars spent on lobbying in the United States for… Continue reading
Aug 11 8 questions about the experimental Ebola drug headed to Africa By Lauran Neergaard, Associated Press The Liberian government said Monday that it will receive doses of the drug to treat two doctors in the country. They would be the first Africans to receive it. Continue reading
Jun 28 Watch Are generic drugs being delayed to market? By PBS News Hour Are generic drugs being delayed to market by so-called "pay for delay" deals between drug companies? The deals happen after generic drug companies challenge the patents on brand-name drugs. The settlements include a date that the generic drug can enter… Continue watching
Apr 23 Watch New Hepatitis-C drug raises hope at a hefty price By PBS News Hour A new drug has a 90 to 100 percent chance of curing the Hepatitis-C virus, but costs tens of thousands of dollars for a course of treatment. The announcement by the manufacturer that it earned more than $2 billion in… Continue watching